{$BSX} отчёт не плохой кстати. Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.25 by 48 percent. This is a 5.13 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $2.66 billion which beat the analyst consensus estimate of $2.52 billion by 5.52 percent. This is a 1.77 percent decrease over sales of $2.71 billion the same period last year.